Atypical Antipsychotics and Seborrheic Dermatitis: Three Case Reports

Abstract

Seborrheic dermatitis (SD) has no diagnostic criteria and its etiology remains unknown. SD is distributed in the areas rich in sebaceous glands. Initially, Malassezia furfur was thought to be the causing agent. Currently, SD is thought as not being proportional to the mean yeast count, but rather as an abnormal host immune response to the yeasts on the skin. There are a variety of topical and systemic antifungal agents available as a remedy. Corticosteroids and ultraviolet B are also used as treatment.

Key words

atypical antipsychotics - seborrheic dermatitis - case reports

References

• 1 Bergbrant IM, Faegemann J. Seborrheic dermatitis and Pityrosporum ovale; A cultural and immunological study.  Acta Derm Venereol. 1989;  69 332-335
• 2 Bonnetblanc JM, Bernard P. Benzoyl peroxide in seborrheic dermatitis.  Arch Dermatol. 1986;  122 752
• 3 Caputo R, Barbareshi M. Itraconazole: New horizons.  G Ital Dermatol Venereol. 2002;  137 1-7
• 4 Cowley NC, Farr PM, Shuster S. The permissive effect of sebum in seborrheic dermatitis: an explanation of the rash in neurological disorders.  Br J Dermatol. 1990;  122 71-76
• 5 Cunha PR. Pimecrolimus cream 1% is effective in seborrhoeic dermatitis refractory to treatment with topical corticosteroids.  Acta Dermato-Venereologica. 2006;  86 69-70
• 6 Faergemann J. Management of seborrheic dermatitis and pityriasis versicolor.  Am J Clin Dermatol. 2000;  1 75-80
• 7 Faeremann J. Seborrheic dermatitis and Pityrosporum orbiculare: Treatment of seborrheic dermatitis of the scalp with miconazole-hydrocortisone (Daktacort), miconazole and hydrocortisone.  Br J Dermatol. 1986;  114 695-700
• 8 Faergemann J, Jones JC, Hettler O, Loria Y. Pityrosporum ovale (Malassezia furfur) as the causative agent of seborrheic dermatitis: New treatment options.  Br J Dermatol. 1996;  134 ((Suppl 46)) 12-15
• 9 Gupta AK, Madzia SE, Barta R. Etiology and management of seborrheic dermatitis.  Dermatology. 2004;  208 89-93
• 10 Gupta AK, Nicol KA. Ciclopirox 1% shampoo for treatment of seborrheic Dermatitis.  Int J Dermatol. 2006;  45 66-69
• 11 Lin AN. Sulphur revisited.  J Am Acad Dermatol. 1988;  18 553-558
• 12 Mastrolonardo M, Diaferio A, Logroscino G. Seborrheic dermatitis, increased sebum excretion, and Parkinson's disease: a survey of impossible links.  Medical Hypothesis. 2003;  60 907-911
• 13 Pierard-Franchimont C, Pierard GE. A double blind placebo-controlled study of ketokonazole and desonide gel combination in the treatment of facial seborrheic dermatitis.  Dermatology. 2002;  204 344-347
• 14 Pirkhammer D, Seeber A, Honigsmann , Ta-new A. Narrow-band ultraviolet B (TL-01) phototherapy is an effective and safe treatment option for patients with severe seborrheic dermatitis.  Br J Dermatol. 2000;  143 964-968
• 15 Rebora A. Patients with mood depression have a high prevalence of seborrhoeic dermatitis.  Acta Derm Venereol. 1990;  70 432-434
• 16 Binder RL, Jonelis FJ. Seborrheic dermatitis: A newly reported side effect of neuroleptics.  J Clin Psychiat. 1984;  45
• 17 Schwartz RA, Janusz CA, Janniger CK. Seborrheic dermatitis: An overview.  Am Fam Physician. 2006;  741 125-130
• 18 Shaw CJ.. , Overview of dermatitis, Up-To-Date 2005.http:// www.utdol.com/application/topic
• 19 Webster G. Seborrheic dermatitis.  Int. J. Dermatol. 1991;  30 843-844
• 20 Wilson CL, Walshe M. Incidence of seborrheic dermatitis in spinal injury patients.  Br J Dermatol. 1988;  33 ((Suppl)) 48

Correspondence